المؤلفون: Ellebaek, Eva, Khan, Shawez, Bastholt, Lars, Schmidt, Henrik, Haslund, Charlotte Aaquist, Donia, Marco, Svane, Inge Marie

المصدر: Ellebaek , E , Khan , S , Bastholt , L , Schmidt , H , Haslund , C A , Donia , M & Svane , I M 2024 , ' PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma ' , European Journal of Cancer , vol. 198 , 113476 . https://doi.org/10.1016/j.ejca.2023.113476Test

مصطلحات موضوعية: Anti-CTLA-4, Anti-PD-1, Immunotherapy, Metastatic melanoma, PD-L1 status, Melanoma/pathology, B7-H1 Antigen, Humans, Ipilimumab/therapeutic use, Combined Modality Therapy, Nivolumab/therapeutic use

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/943acb35-2610-46a6-be1c-a947c2a509bbTest

الإتاحة: https://doi.org/10.1016/j.ejca.2023.113476Test
https://portal.findresearcher.sdu.dk/da/publications/943acb35-2610-46a6-be1c-a947c2a509bbTest
https://findresearcher.sdu.dk/ws/files/252954354/1-s2.0-S0959804923007785-main.pdfTest

المؤلفون: Rossi, E., Boldrini, L., Maratta, M.G., Gatta, R., Votta, C., Tortora, G., Schinzari, G.

المصدر: Human vaccines & immunotherapeutics, vol. 19, no. 1, pp. 2172926

مصطلحات موضوعية: Humans, Carcinoma, Renal Cell/diagnostic imaging, Renal Cell/therapy, Retrospective Studies, Antineoplastic Agents, Immunological/therapeutic use, Immunotherapy/methods, Kidney Neoplasms/diagnostic imaging, Kidney Neoplasms/therapy, Ipilimumab/therapeutic use, Radiomics, anti-CTLA4, anti-PD-1, features, immunotherapy, ipilimumab, nivolumab, pembrolizumab, predictive factor, renal cell carcinoma

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36723981; info:eu-repo/semantics/altIdentifier/eissn/2164-554X; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BFEA01D27F957; https://serval.unil.ch/notice/serval:BIB_BFEA01D27F95Test; urn:issn:2164-5515; https://serval.unil.ch/resource/serval:BIB_BFEA01D27F95.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_BFEA01D27F957Test

الإتاحة: https://doi.org/10.1080/21645515.2023.2172926Test
https://serval.unil.ch/notice/serval:BIB_BFEA01D27F95Test
https://serval.unil.ch/resource/serval:BIB_BFEA01D27F95.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_BFEA01D27F957Test

المؤلفون: van Zeijl, Michiel C T, van Breeschoten, Jesper, de Wreede, Liesbeth C, Wouters, Michel W J M, Hilarius, Doranne L, Blank, Christian U, Aarts, Maureen J B, van den Berkmortel, Franchette W P J, de Groot, Jan Willem B, Hospers, Geke A P, Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S, Stevense-den Boer, Marion A, van der Veldt, Astrid A M, Vreugdenhil, Gerard, Boers-Sonderen, Marye J, Suijkerbuijk, Karijn P M, Haanen, John B A G, van den Eertwegh, Alfons J M

المصدر: van Zeijl , M C T , van Breeschoten , J , de Wreede , L C , Wouters , M W J M , Hilarius , D L , Blank , C U , Aarts , M J B , van den Berkmortel , F W P J , de Groot , J W B , Hospers , G A P , Kapiteijn , E , Piersma , D , van Rijn , R S , Stevense-den Boer , M A , van der Veldt , A A M , Vreugdenhil , G , Boers-Sonderen , M J ....

مصطلحات موضوعية: Humans, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Brain Neoplasms/drug therapy, Ipilimumab/therapeutic use, Melanoma/pathology, Netherlands, Nivolumab/therapeutic use

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/efed156f-7b5b-414a-a016-bf59943ddcb8Test

الإتاحة: https://doi.org/10.1097/CJI.0000000000000468Test
https://hdl.handle.net/11370/efed156f-7b5b-414a-a016-bf59943ddcb8Test
https://research.rug.nl/en/publications/efed156f-7b5b-414a-a016-bf59943ddcb8Test
https://pure.rug.nl/ws/files/702846424/Real_world_Outcomes_of_Ipilimumab_Plus_Nivolumab.5.pdfTest

المؤلفون: Pires da Silva, I., Zakria, D., Ahmed, T., Trojanello, C., Dimitriou, F., Allayous, C., Gerard, C., Zimmer, L., Lo, S., Michielin, O., Lebbe, C., Mangana, J., Ascierto, P.A., Johnson, D.B., Carlino, M., Menzies, A., Long, G.

المصدر: Journal for immunotherapy of cancer, vol. 10, no. 7, pp. e004610

مصطلحات موضوعية: Brain Neoplasms/drug therapy, Female, Humans, Ipilimumab/therapeutic use, Melanoma/drug therapy, Melanoma/genetics, Melanoma/pathology, Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors, Mutation, Neoplasms, Second Primary/drug therapy, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Proto-Oncogene Proteins B-raf/genetics, Skin Neoplasms/drug therapy, Skin Neoplasms/genetics, Skin Neoplasms/pathology, immunotherapy, melanoma

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35798536; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D204CE09BBCB7; https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test

الإتاحة: https://doi.org/10.1136/jitc-2022-004610Test
https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest
https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test

المؤلفون: van Not, Olivier J, Blokx, Willeke A M, van den Eertwegh, Alfons J M, de Meza, Melissa M, Haanen, John B, Blank, Christian U, Aarts, Maureen J B, van den Berkmortel, Franchette W P J, de Groot, Jan Willem B, Hospers, Geke A P, Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S, Stevense-den Boer, Marion, van der Veldt, Astrid A M, Boers-Sonderen, Marye J, Jansen, Anne M L, Wouters, Michel W J M, Suijkerbuijk, Karijn P M

المصدر: van Not , O J , Blokx , W A M , van den Eertwegh , A J M , de Meza , M M , Haanen , J B , Blank , C U , Aarts , M J B , van den Berkmortel , F W P J , de Groot , J W B , Hospers , G A P , Kapiteijn , E , Piersma , D , van Rijn , R S , Stevense-den Boer , M , van der Veldt , A A M , Boers-Sonderen , M J , Jansen , A ....

مصطلحات موضوعية: Cohort Studies, GTP Phosphohydrolases/genetics, Humans, Immune Checkpoint Inhibitors/pharmacology, Ipilimumab/therapeutic use, Melanoma/drug therapy, Membrane Proteins/genetics, Mutation, Nivolumab/therapeutic use, Proto-Oncogene Proteins B-raf/genetics

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/7be08e18-b442-427d-a567-d29f6596de95Test

الإتاحة: https://doi.org/10.1200/PO.22.00018Test
https://hdl.handle.net/11370/7be08e18-b442-427d-a567-d29f6596de95Test
https://research.rug.nl/en/publications/7be08e18-b442-427d-a567-d29f6596de95Test
https://pure.rug.nl/ws/files/246030355/po.22.00018.pdfTest

المؤلفون: van Not, Olivier J, de Meza, Melissa M, van den Eertwegh, Alfons J M, Haanen, John B, Blank, Christian U, Aarts, Maureen J B, van den Berkmortel, Franchette W P J, van Breeschoten, Jesper, de Groot, Jan-Willem B, Hospers, Geke A P, Ismail, Rawa K, Kapiteijn, Ellen, Piersma, Djura, van Rijn, Roos S, Stevense-den Boer, Marion A M, van der Veldt, Astrid A M, Vreugdenhil, Gerard, Bonenkamp, Han J, Boers-Sonderen, Marye J, Blokx, Willeke A M, Wouters, Michel W J M, Suijkerbuijk, Karijn P M

المصدر: van Not , O J , de Meza , M M , van den Eertwegh , A J M , Haanen , J B , Blank , C U , Aarts , M J B , van den Berkmortel , F W P J , van Breeschoten , J , de Groot , J-W B , Hospers , G A P , Ismail , R K , Kapiteijn , E , Piersma , D , van Rijn , R S , Stevense-den Boer , M A M , van der Veldt , A A M , Vreugdenhil , G ....

مصطلحات موضوعية: Cohort Studies, Humans, Immune Checkpoint Inhibitors/therapeutic use, Ipilimumab/therapeutic use, Melanoma/mortality, Nivolumab/adverse effects, Prospective Studies, Skin Neoplasms/drug therapy

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/4eaf37d0-e9eb-444d-8275-f8aa051f3a33Test

الإتاحة: https://doi.org/10.1016/j.ejca.2022.02.026Test
https://hdl.handle.net/11370/4eaf37d0-e9eb-444d-8275-f8aa051f3a33Test
https://research.rug.nl/en/publications/4eaf37d0-e9eb-444d-8275-f8aa051f3a33Test
https://pure.rug.nl/ws/files/218331244/1_s2.0_S0959804922001241_main.pdfTest

المؤلفون: Adler, Amanda, Slayen, Samuel, Stegenga, Heather, Guo, Yelan, Diaz, Richard, Welton, Nicky J, Westwood, Nigel, Doull, Iolo, Crawley, Charles

المصدر: Adler , A , Slayen , S , Stegenga , H , Guo , Y , Diaz , R , Welton , N J , Westwood , N , Doull , I & Crawley , C 2022 , ' NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma ' , Lancet Respiratory Medicine , vol. 10 , no. 10 , pp. e92-e93 . https://doi.org/10.1016/S2213-2600Test(22)00301-0

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Humans, Ipilimumab/therapeutic use, Mesothelioma/drug therapy, Mesothelioma, Malignant/drug therapy, Nivolumab/therapeutic use, Pleural Neoplasms/drug therapy

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/S2213-2600Test(22)00301-0
https://hdl.handle.net/1983/3a0ea762-aed1-49bd-8829-dcb978a92a13Test
https://research-information.bris.ac.uk/en/publications/3a0ea762-aed1-49bd-8829-dcb978a92a13Test
https://research-information.bris.ac.uk/ws/files/333654671/Nivolumab_ipilimumb_mesothelioma_v0.9.pdfTest

المؤلفون: Fietz, Simon, Zarbl, Romina, Niebel, Dennis, Posch, Christian, Brossart, Peter, Gielen, Gerrit H., Strieth, Sebastian, Pietsch, Torsten, Kristiansen, Glen, Bootz, Friedrich, Landsberg, Jennifer, Dietrich, Dimo

المصدر: http://lobid.org/resources/99370671253406441Test#!, 70(6):1781-1788.

مصطلحات موضوعية: Gene Expression Regulation, Neoplastic [MeSH], Research Report, CTLA-4, Aged, 80 and over [MeSH], Melanoma, Aged [MeSH], Male [MeSH], Melanoma/pathology [MeSH], DNA methylation, Melanoma/drug therapy [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Melanoma/mortality [MeSH], Predictive biomarker, Ipilimumab/therapeutic use [MeSH], Survival Rate [MeSH], CTLA-4 Antigen/genetics [MeSH], DNA Methylation [MeSH], Antineoplastic Agents, Immunological/therapeutic use [MeSH], Biomarkers, Tumor/genetics [MeSH], Immunotherapy, Prognosis [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6470084Test; https://doi.org/10.1007/s00262-020-02777-4Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139923Test/

الإتاحة: https://doi.org/10.1007/s00262-020-02777-4Test
https://repository.publisso.de/resource/frl:6470084Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139923Test/

المؤلفون: Olivier J. van Not, Melissa M. de Meza, Alfons J.M. van den Eertwegh, John B. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jesper van Breeschoten, Jan-Willem B. de Groot, Geke A.P. Hospers, Rawa K. Ismail, Ellen Kapiteijn, Djura Piersma, Roos S. van Rijn, Marion A.M. Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Han J. Bonenkamp, Marye J. Boers-Sonderen, Willeke A.M. Blokx, Michel W.J.M. Wouters, Karijn P.M. Suijkerbuijk

المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: European journal of cancer (Oxford, England : 1990), 167, 70-80. Elsevier Ltd.
van Not, O J, de Meza, M M, van den Eertwegh, A J M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, van Breeschoten, J, de Groot, J-W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Bonenkamp, H J, Boers-Sonderen, M J, Blokx, W A M, Wouters, M W J M & Suijkerbuijk, K P M 2022, ' Response to immune checkpoint inhibitors in acral melanoma : A nationwide cohort study ', European Journal of Cancer, vol. 167, pp. 70-80 . https://doi.org/10.1016/j.ejca.2022.02.026Test
European Journal of Cancer, 167, 70-80. ELSEVIER SCI LTD
European Journal of Cancer, 167, pp. 70-80
European Journal of Cancer, 167, 70-80
European Journal of Cancer, 167, 70-80. Pergamon

مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Survival, Melanoma/mortality, THERAPY, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], SUBTYPES, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Immune checkpoint inhibitors, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Skin Neoplasms/drug therapy, Humans, Prospective Studies, Melanoma, OUTCOMES, Response, KIT, EFFICACY, Nivolumab/adverse effects, Ipilimumab, Immune Checkpoint Inhibitors/therapeutic use, MUCOSAL, Nivolumab, Oncology, ARM, Immunotherapy, Ipilimumab/therapeutic use

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e0333d1ed14f8c5e0b759f512b98e9Test
http://www.scopus.com/inward/record.url?scp=85127559750&partnerID=8YFLogxKTest

المؤلفون: Paz-Ares, L.G., Ciuleanu, T.E., Pluzanski, A., Lee, J.S., Gainor, J.F., Otterson, G.A., Audigier-Valette, C., Ready, N., Schenker, M., Linardou, H., Caro, R.B., Provencio, M., Zurawski, B., Lee, K.H., Kim, S.W., Caserta, C., Ramalingam, S.S., Spigel, D.R., Brahmer, J.R., Reck, M., O'Byrne, K.J., Girard, N., Popat, S., Peters, S., Memaj, A., Nathan, F., Aanur, N., Borghaei, H.

المصدر: Journal of thoracic oncology, vol. 18, no. 1, pp. 79-92

مصطلحات موضوعية: Humans, Nivolumab/pharmacology, Nivolumab/therapeutic use, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, Lung Neoplasms/pathology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/chemically induced, Immune-mediated adverse events, Ipilimumab, NSCLC, Nivolumab, Safety

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36049658; info:eu-repo/semantics/altIdentifier/eissn/1556-1380; https://serval.unil.ch/notice/serval:BIB_0FB9CAD0B375Test; urn:issn:1556-0864

الإتاحة: https://doi.org/10.1016/j.jtho.2022.08.014Test
https://serval.unil.ch/notice/serval:BIB_0FB9CAD0B375Test